Exchange: NASDAQ·Updated 07:30 PM EDT
SABS logo

SABS SAB Biotherapeutics Inc

$3.51
$0.01
(0.29%)
Today
Closed $3.51
$0.00
(0.00%)
After Hours
EarningsNov 12
Mkt Cap$319.36M
Vol1.97M

About SABS

SAB Biotherapeutics, Inc. is a clinical-stage, biopharmaceutical company, which engages in advancing a new class of immunotherapies leveraging fully-human polyclonal antibodies. It produces human polyclonal immunotherapies and its versatile DiversitAb platform is applicable for unmet needs in human diseases. The company was founded by Eddie J. Sullivan and Christine E. Hamilton in July 2014 and is headquartered in Miami Beach, FL.
73

Bullish Sentiment

How do you feel about SABS?

Advertisement|Remove ads.